- Type / Class
- Equity / COM
- Total 13F shares
- 4,736
- Share change
- +3,602
- Total reported value
- $16,623
- Price per share
- $3.51
- Number of holders
- 3
- Value change
- +$11,976
- Number of buys
- 3
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 29273B500?
CUSIP 29273B500 identifies NDRA - ENDRA Life Sciences Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29273B500:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Michael Milos Thornton |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
34,139
|
$56,329 | — | 18 May 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
1,130
|
$4,633 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
4
|
$16 | — | 31 Mar 2025 | |
| UBS Group AG |
3/4/5
|
Market maker/broker-dealer |
—
class O/S missing
|
292,024
|
— | — | 27 Aug 2024 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - COM (NDRA) as of Q2 2025
As of 30 Jun 2025,
ENDRA Life Sciences Inc. - COM (NDRA) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,736 shares.
The largest 3 holders included
UBS Group AG, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and BANK OF AMERICA CORP /DE/.
This page lists
3
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
2
Q2 2025 holders
3
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.